Crossmark

mBC: ADC werden in der Therapielinie weiter nach vorne rücken

Crossref DOI link: https://doi.org/10.1007/s15015-025-4482-9

Published Online: 2026-02-05

Published Print: 2026-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pohlmann, Birgit-Kristin
License Information

Text and Data Mining valid from 2026-02-01

Version of Record valid from 2026-02-01
More Information

Article History

First Online: 5 February 2026

Free to read: This content has been made available to all.